You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Regeneron
Health
Disability
Diabetes
Rare Diseases
Cancer
Diet and Fitness
Obesity
Antibiotic Resistance
Alopecia
Heart Disease
Mental Health
Reproductive Health
Topics

Advertisement

Regeneron

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Yesterday

This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested The Motley Fool 01:32 Sun, 28 Jun

Friday

How Investors May Respond To Regeneron Pharmaceuticals (REGN) Cemdisiran Priority Review for gMG Treatment Simply Wall St 20:53 Fri, 26 Jun

Thursday

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast Regeneron Pharmaceuticals (Press Release) 21:12 Thu, 25 Jun

Advertisement

Advertisement

Tuesday

Regeneron's Applications for gMG Drug Accepted by FDA and EMA Zacks 20:32 Tue, 23 Jun

2 Underrated Weight Loss Stocks to Buy and Hold The Motley Fool 07:55 Tue, 23 Jun

In the last month

Regeneron’s New Drug Application for cemdisiran accepted for review by FDA and EMA PMLiVE 12:32 Mon, 22 Jun

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) Regeneron Pharmaceuticals (Press Release) 12:01 Mon, 22 Jun

Regeneron (REGN) Stock Valuation After WHO Ebola Trial Backing And Expanding R&D Collaborations Simply Wall St 10:20 Sat, 13 Jun

Regn Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm Business Wire (Press Release) 20:09 Wed, 10 Jun

How WHO’s Maftivimab Priority for Bundibugyo Trials At Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story Simply Wall St 10:26 Wed, 10 Jun

Spotlight On: Biosimilar Litigations - June 2026 JD Supra 17:33 Fri, 05 Jun

REGN Expands Cancer Deal With CytomX for Bispecific Therapeutics Zacks 19:34 Thu, 04 Jun

Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - Regn PR Newswire (Press Release) 15:13 Thu, 04 Jun

CytomX Secures $37M Regeneron Pact; Analyst Sets Price Target At $11 RTT News 14:53 Thu, 04 Jun

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO Regeneron Pharmaceuticals (Press Release) 12:07 Thu, 04 Jun

Advertisement

Regeneron and CytomX extend cancer therapy partnership to $4bn deal Hospital Management 10:07 Thu, 04 Jun

Cytomx, Regeneron expand bispecifics deal to potential $4B BioWorld 21:35 Wed, 03 Jun

Are Options Traders Betting on a Big Move in Regeneron Stock? Zacks 15:25 Tue, 02 Jun

Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound? (Revised) Zacks 16:36 Mon, 01 Jun

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength (Revised) Zacks 16:36 Mon, 01 Jun

WHO Ebola Trial Puts Regeneron’s Maftivimab Platform In Investor Focus Simply Wall St 02:15 Sun, 31 May

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS